Familial AD is associated with mutations in amyloid precursor protein APP, and presenilins (PS1 and PS2), while late-onset AD is associated with mutations in APOE and other genes involved in vascular dysfunction, immunity and inflammation, cholesterol metabolism, endocytosis, and ubiquitination [2]. Here, APP is linked to Onset.